| 國家衛生研究院 |
2004-07 |
Recent advances in non-surgical treatment for advanced hepatocellular carcinoma
|
Hsu, C;Cheng, JCH;Cheng, AL |
| 國家衛生研究院 |
2004-07 |
Comparison of the antitumor activity of thalidomide between hepatitis B (HBV)and hepatitis C (HCV)-related hepatocellular carcinoma (HCC)
|
Hsu, C;Chen, LT;Lai, MY;Yeh, KH;Lee, PH;Cheng, AL |
| 國家衛生研究院 |
2004-05-04 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu, C; Shen, YC; Yang, CH; Yeh, KH; Lu, YS; Hsu, CH; Liu, HT; Li, CC; Chen, JS; Wu, CY; Cheng, AL |
| 國立臺灣大學 |
2004-05 |
Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
|
Lu, YS; Hsu, C; Li, CC; Kuo, SH; Kun-Huei, Yeh; Yang, CH; Hsu, CH; Wu, CY; Cheng, AL. |
| 國立臺灣大學 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 臺大學術典藏 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C;Shen YC;Yang CH;Kun-Huei Yeh;Lu YS;Hsu CH;Liu HT;Li CC;Chen JS;Wu CY;Cheng AL; Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 臺北醫學大學 |
2004 |
Functional domain and motif analysis of androgen receptor coregulator ARA70 and its differential expression in prostate cancer
|
葉劭德; Hu YC; Yeh S; Yeh SD; Sampson ER; Huang J; Li P; Hsu C; Ting HJ; Lin HK; Wang L; Kim E; Ni J; Chang C |
| 臺北醫學大學 |
2004 |
Introduction of prototype for Stroke Prevention Center.
|
邱弘毅; Chiou HY;Chiu WT;Chen YH;Hsieh YC;Hsu C; |
| 臺大學術典藏 |
2004 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; CHIH-HUNG HSU; Liu H.-T.; Hsu C.; Hsu C.;Shen Y.-C.;Yang C.-H.;Yeh K.-H.;Lu Y.-S.;Chih-Hung Hsu;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Cheng A.-L.; Wu C.-Y.; Li C.-C.; Chen J.-S. |
| 國家衛生研究院 |
2003-12 |
Factors contributing to health behaviors among the elderly in Taiwan
|
Hsu, C;Hsu, H;Shu, C;Shih, Y;Tai, T |
| 國立臺灣大學 |
2003-12 |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma.
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Yang, PM; Lai, MY; Lee, PH; Cheng, AL |
| 國家衛生研究院 |
2003-11 |
Use of power Doppler sonography and circulating angiogenic factors to assess the potential antiangiogenic effect of thalidomide in hepatocellular carcinoma
|
Hsu, C;Chen, HN;Chen, LT;Wu, CY;Hsieh, FJ;Cheng, AL |
| 國家衛生研究院 |
2003-10 |
An investigation of gradient-based reconstruction algorithms for statistical PET transmission imaging
|
Chang, M;Hsu, C |
| 國立臺灣大學 |
2003-01 |
Rejoinder for “Hsu C, et al. survival-weighted health profile for long-term survivors of acute myelogenous leukemia”.
|
Hsu, C.; Wang, J. D.; Yao, G.; Tang, G. L. |
| 國家衛生研究院 |
2003 |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Yang, PM; Lai, MY; Lee, PH; Cheng, AL |
| 高雄醫學大學 |
2003 |
熱修克前處理可預防敗血症時心臟粒線體功能缺失
|
陳香文;許勤;呂宗禧;王淑容;楊瑞成 ; Chen HW;Hsu C;Lu TS;Wang SJ;Yang RC |
| 高雄醫學大學 |
2003 |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma.
|
陳立宗;鄭安理 ; Hsu C;Chen CN;Chen LT;Wu CY;Yang PM;Lai MY;Lee PH;Cheng AL. |
| 高雄醫學大學 |
2003 |
抑制PKC alpha可經由負向調控Bcl-xL而引起肝臟上皮細胞的凋亡
|
謝雅晶;饒曉菁;楊瑞成;許勝光;許勤 ; Hsieh YC;Jao HC;Yang RC;Hsu HK;Hsu C |
| 國立臺灣大學 |
2003 |
Towards PKI Interoperability: Lessons from a BS7799 Accreditation Scheme
|
Backhouse, J.; Hsu, C; McDonell, A. |
| 臺大學術典藏 |
2003 |
Strong green luminescence in quaternary InAlGaN thin films
|
Feng, S.-W.; Cheng, Y.-C.; Chung, Y.-Y.; Yang, C.C.; Ma, K.-J.; Yan, C.-C.; Hsu, C.; Lin, J.Y.; Jiang, H.X.; CHIH-CHUNG YANG |
| 臺大學術典藏 |
2003 |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
|
Hsu C.;Chiung-Nien Chen;Chen L.-T.;Wu C.-Y.;Yang P.-M.;Lai M.-Y.;Lee P.-H.;Cheng A.-L.; Hsu C.; CHIUNG-NIEN CHEN; Cheng A.-L.; Chen L.-T.; Wu C.-Y.; Yang P.-M.; Lai M.-Y.; Lee P.-H. |
| 國立臺灣大學 |
2002 |
Information Systems Security Education: A Situated Learning Strategy
|
Hsu, C.; Backhouse, J. |
| 臺大學術典藏 |
2002 |
Impact of localized states on the recombination dynamics in InGaN/GaN quantum well structures
|
Feng, S.-W.; Cheng, Y.-C.; Chung, Y.-Y.; Yang, C.C.; Lin, Y.-S.; Hsu, C.; Ma, K.-J.; Chyi, J.-I.; CHIH-CHUNG YANG |
| 國家衛生研究院 |
2001-11 |
Use of thalidomide in the treatment of advanced hepatocellular carcinoma (HCC): With emphasis on using power Doppler sonography to evaluate the vascularity of the tumor and its correlation with tumor response
|
Hsu, C;Chen, C;Chen, L;Wu, C;Hsieh, F;Cheng, A |
| 國家衛生研究院 |
2001-01-01 |
Comparison of MALT and non-MALT primary large cell lymphoma of the stomach - Does histologic evidence of MALT affect chemotherapy response?
|
Hsu, C; Chen, CL; Chen, LT; Liu, HT; Chen, YC; Jan, CM; Liu, CS; Cheng, AL |
